Associations of Interleukin-5 With Plaque Development and Cardiovascular Events.

Knutsson, Anki; Björkbacka, Harry; Dunér, Pontus; Engström, Gunnar; Binder, Christoph J; Nilsson, Anna Hultgårdh; Nilsson, Jan

Knutsson, Anki; Björkbacka, Harry; Dunér, Pontus; Engström, Gunnar; Binder, Christoph J; Nilsson, Anna Hultgårdh; Nilsson, Jan.

Afiliación

Knutsson A; Department of Experimental Medical Science, Lund University, Lund, Sweden.
Björkbacka H; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Dunér P; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Engström G; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Binder CJ; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Nilsson AH; Department of Experimental Medical Science, Lund University, Lund, Sweden.
Nilsson J; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

JACC Basic Transl Sci ; 4(8): 891-902, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31909299

Palabras clave

ApoE, apolipoprotein E; CVD, cardiovascular disease; HR, hazard ratio; IL-5, interleukin-5; ILC2, type 2 innate lymphoid cells; MACE, major adverse cardiac events; OR, odds ratio; atherosclerosis; interleukin 5; myocardial infarction; stroke

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: JACC Basic Transl Sci Año: 2019 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google